Chu Michael J J, Vather Ryash, Hickey Anthony J R, Phillips Anthony R J, Bartlett Adam S J R
Department of Surgery, University of Auckland, Auckland, New Zealand.
HPB (Oxford). 2015 Jan;17(1):1-10. doi: 10.1111/hpb.12258. Epub 2014 Apr 9.
Steatotic livers are vulnerable to the deleterious effects of ischaemia-reperfusion injury (IRI) that occur after hepatic surgery. Ischaemic preconditioning (IPC) has been shown to abrogate the effects of IRI in patients undergoing hepatic surgery. Experimental studies have suggested that IPC may be beneficial in steatotic livers subjected to IRI.
The aim of this systematic review was to evaluate the effects of IPC on steatotic livers following hepatic IRI in experimental models.
An electronic search of the OVID Medline and EMBASE databases was performed to identify studies that reported clinically relevant outcomes in animal models of hepatic steatosis subjected to IPC and IRI.
A total of 1093 articles were identified, of which 18 met the inclusion criteria. There was considerable heterogeneity in the type of animal model, and duration and type of IRI. Increased macrovesicular steatosis (> 30%) was associated with a poor outcome following IRI. Ischaemic preconditioning was found to be beneficial in > 30% steatotic livers and provided for decreased histological damage, improved liver function findings and increased survival.
Experimental evidence supports the use of IPC in steatotic livers undergoing IRI. These findings may be applicable to patients undergoing liver surgery. However, clinical studies are required to validate the efficacy of IPC in this setting.
脂肪变性的肝脏易受肝脏手术后发生的缺血再灌注损伤(IRI)的有害影响。缺血预处理(IPC)已被证明可消除肝脏手术患者IRI的影响。实验研究表明,IPC可能对遭受IRI的脂肪变性肝脏有益。
本系统评价的目的是评估IPC对实验模型中肝脏IRI后脂肪变性肝脏的影响。
对OVID Medline和EMBASE数据库进行电子检索,以识别报告在接受IPC和IRI的肝脂肪变性动物模型中临床相关结果的研究。
共识别出1093篇文章,其中18篇符合纳入标准。动物模型类型、IRI持续时间和类型存在相当大的异质性。大泡性脂肪变性增加(>30%)与IRI后的不良结局相关。发现缺血预处理对>30%的脂肪变性肝脏有益,并可减少组织学损伤、改善肝功能结果和提高生存率。
实验证据支持在遭受IRI的脂肪变性肝脏中使用IPC。这些发现可能适用于接受肝脏手术的患者。然而,需要进行临床研究以验证IPC在这种情况下的疗效。